A215570 Stock Overview
Engages in the research and development of medicines and raw materials for medical research. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cronex.Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩499.00 |
52 Week High | ₩1,698.00 |
52 Week Low | ₩366.00 |
Beta | 0 |
11 Month Change | -0.20% |
3 Month Change | -9.11% |
1 Year Change | -57.85% |
33 Year Change | -87.52% |
5 Year Change | -86.80% |
Change since IPO | -91.52% |
Recent News & Updates
Recent updates
Shareholder Returns
A215570 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | -0.2% | -9.0% | -2.8% |
1Y | -57.9% | 33.1% | -3.4% |
Return vs Industry: A215570 underperformed the KR Life Sciences industry which returned 33.1% over the past year.
Return vs Market: A215570 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
A215570 volatility | |
---|---|
A215570 Average Weekly Movement | 17.2% |
Life Sciences Industry Average Movement | 8.8% |
Market Average Movement | 5.7% |
10% most volatile stocks in KR Market | 11.5% |
10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A215570's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A215570's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | n/a | Young-Joon Son | www.cronex.co.kr |
Cronex Co.,Ltd engages in the research and development of medicines and raw materials for medical research. The company offers contract research organization services for dental materials, various implant materials, bone marrow restorations, and bone regeneration, skin penetration, high-frequency therapy device, patch drug test, biological dressing material, wound dressing, franz diffusion test skin; spinal implant efficacy evaluation, bone defect bone graft material efficacy evaluation, cartilage regeneration efficacy evaluation, X-ray, micro-CT, and histology; drug effectiveness evaluation experiments for new drug development using minipigs, beagle dogs, and rabbits; preclinical efficacy evaluation using medium-sized animals; and test progress, animal management, animal anesthesia, post-test management of animals, sampling, and test evaluation services.
Cronex.Co.,Ltd Fundamentals Summary
A215570 fundamental statistics | |
---|---|
Market cap | ₩1.59b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A215570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A215570 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A215570 perform over the long term?
See historical performance and comparison